Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.420 CAD | -5.96% |
|
+0.71% | -32.70% |
07-03 | Healwell AI Inc. - Shareholder/Analyst Call | |
06-11 | Healwell AI Inc. Announces Strategic Expansion into the U.S. Healthcare Market | CI |
Company Valuation: Healwell AI Inc.
Data adjusted to current consolidation scope
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 61.13 | 30.05 | 65.99 | 356 | 377.4 | - | - |
Change | - | -50.85% | 119.64% | 439.5% | 5.99% | - | - |
Enterprise Value (EV) 1 | 55.71 | 35.67 | 65.99 | 356 | 392.6 | 378.3 | 299.3 |
Change | - | -35.97% | 85.01% | 439.5% | 10.26% | -3.64% | -20.89% |
P/E ratio | -3.79x | -1.43x | -1.36x | -11.1x | -12.3x | -63.1x | - |
PBR | - | - | - | - | - | - | - |
PEG | - | -0.1x | -0x | 0.2x | 0.3x | 0.8x | - |
Capitalization / Revenue | 1.28x | 0.56x | 9.02x | 9.14x | 2.76x | 1.97x | 1.69x |
EV / Revenue | 1.17x | 0.67x | 9.02x | 9.14x | 2.87x | 1.97x | 1.34x |
EV / EBITDA | -12x | -3.81x | -8.3x | -22.2x | 139x | 22.3x | 11x |
EV / EBIT | -3.7x | - | -3.92x | -10.6x | -17.9x | -54.5x | 151x |
EV / FCF | -7.02x | -4.12x | - | -13.5x | -35.4x | 30.4x | 15x |
FCF Yield | -14.2% | -24.3% | - | -7.4% | -2.83% | 3.29% | 6.69% |
Dividend per Share 2 | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - |
EPS 2 | -0.33 | -0.42 | -0.55 | -0.19 | -0.1156 | -0.0225 | - |
Distribution rate | - | - | - | - | - | - | - |
Net sales 1 | 47.82 | 53.22 | 7.317 | 38.97 | 136.8 | 191.7 | 223.4 |
EBITDA 1 | -4.644 | -9.356 | -7.954 | -16 | 2.831 | 16.93 | 27.11 |
EBIT 1 | -15.06 | - | -16.82 | -33.58 | -21.9 | -6.94 | 1.98 |
Net income 1 | -15.67 | - | -31.54 | -25.46 | -26.33 | -8.195 | 3.78 |
Net Debt 1 | -5.422 | 5.623 | - | - | 15.2 | 0.9 | -78.1 |
Reference price 2 | 1.250 | 0.600 | 0.750 | 2.110 | 1.420 | 1.420 | 1.420 |
Nbr of stocks (in thousands) | 48,905 | 50,075 | 87,987 | 168,729 | 265,741 | - | - |
Announcement Date | 3/31/22 | 3/31/23 | 3/28/24 | 3/26/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E ratio, Detailed evolution
P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
---|---|---|---|---|---|---|
-13.07x | 3.04x | 146.96x | - | 293M | ||
53.68x | 12.87x | 28.68x | -.--% | 46.16B | ||
302.83x | 161.21x | 210.88x | 0.16% | 22.57B | ||
128.31x | 18.47x | 84.73x | 0.58% | 7.26B | ||
-135.29x | - | - | - | 1.62B | ||
-11.51x | 0.8x | 10.89x | 2.37% | 1.33B | ||
-694.5x | - | - | -.--% | 1.3B | ||
53.32x | 8.72x | 18.62x | 0.83% | 1.28B | ||
60.43x | - | - | 0.27% | 1.2B | ||
Average | -28.42x | 34.19x | 83.46x | 0.6% | 9.22B | |
Weighted average by Cap. | 111.34x | 55.51x | 85.94x | 0.15% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- AIDX Stock
- Valuation Healwell AI Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition